Top compounds associated with response to LMNTD2


Feature Type Standardized
Nominal ANOVA
mRNA STF-31 CTRPv2 pan-cancer AAC -0.018 0.6
mRNA vincristine CTRPv2 pan-cancer AAC -0.015 0.6
mRNA tivantinib CTRPv2 pan-cancer AAC -0.022 0.6
mRNA NSC-87877 GDSC1000 pan-cancer AAC -0.018 0.6
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC 0.016 0.6
mRNA Panobinostat CCLE pan-cancer AAC -0.02 0.6
mRNA linifanib CTRPv2 pan-cancer AAC -0.017 0.6
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.6
mRNA B02 CTRPv2 pan-cancer AAC 0.017 0.6
mRNA AGK-2 CTRPv2 pan-cancer AAC 0.018 0.6
Download CSV